CoDa Therapeutics Closes B Round with $40 Million from Rusnano/ Domain-Led Syndicate

Wound healing company CoDa Therapeutics is the first Domain portfolio company to benefit from the venture capital firm’s new, $760 million partnership with Russian sovereign fund Rusnano